{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:11:42Z","timestamp":1794028302604,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272785"],"award-info":[{"award-number":["82272785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504849"],"award-info":[{"award-number":["82504849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["242300421198"],"award-info":[{"award-number":["242300421198"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252300421126"],"award-info":[{"award-number":["252300421126"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252300423784"],"award-info":[{"award-number":["252300423784"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.phrs.2026.108118","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:31:02Z","timestamp":1769844662000},"page":"108118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A novel peptide blocking CD93\/IGFBP7 interaction normalizes tumor vessels and synergizes with radiotherapy for cancer immunotherapy"],"prefix":"10.1016","volume":"225","author":[{"given":"Yuzhen","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.phrs.2026.108118_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41568-024-00736-0","article-title":"Targeting the tumour vasculature: from vessel destruction to promotion","volume":"24","author":"Guelfi","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.108118_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune-vascular crosstalk for cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.108118_bib3","article-title":"A vascularized tumors-on-a-chip model for studying tumor-angiogenesis interplay, heterogeneity and drug responses","volume":"32","author":"Shin","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","article-title":"Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments","volume":"20","author":"Wei","year":"2021","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.phrs.2026.108118_bib5","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/acs.accounts.9b00283","article-title":"Smart nanotherapeutic targeting of tumor vasculature","volume":"52","author":"Li","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"10.1016\/j.phrs.2026.108118_bib6","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"issue":"2","key":"10.1016\/j.phrs.2026.108118_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10456-022-09863-4","article-title":"Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy","volume":"26","author":"Nowak-Sliwinska","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phrs.2026.108118_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin\u00ae) in cancer treatment: a review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/0008-5472.CAN-21-3515","article-title":"Antiangiogenesis: vessel regression, vessel normalization, or Both?","volume":"82","author":"Augustin","year":"2022","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.phrs.2026.108118_bib11","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/s12276-023-01114-w","article-title":"Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy","volume":"55","author":"Choi","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2026.108118_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180622","article-title":"Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity","volume":"135","author":"Zhang","year":"2025","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.phrs.2026.108118_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006680","article-title":"Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody","volume":"11","author":"Park","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"604","key":"10.1016\/j.phrs.2026.108118_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8922","article-title":"Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy","volume":"13","author":"Sun","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.phrs.2026.108118_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2013.06.004","article-title":"A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis","volume":"24","author":"Masiero","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2026.108118_bib16","article-title":"CD93 correlates with immune infiltration and impacts patient immunotherapy efficacy: a pan-cancer analysis","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"18","key":"10.1016\/j.phrs.2026.108118_bib17","article-title":"Ultrasound imaging of tumor vascular CD93 with MMRN2 modified microbubbles for immune microenvironment prediction","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.phrs.2026.108118_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.str.2023.12.011","article-title":"Structural insight into CD93 recognition by IGFBP7","volume":"32","author":"Xu","year":"2024","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00441-021-03543-3","article-title":"CD93 a potential player in cytotrophoblast and endothelial cell migration","volume":"387","author":"Fantone","year":"2022","journal-title":"Cell Tissue Res."},{"issue":"6","key":"10.1016\/j.phrs.2026.108118_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/biom13060910","article-title":"Diagnostic and prognostic role of CD93 in cardiovascular disease: a systematic review","volume":"13","author":"Piani","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2026.108118_bib21","doi-asserted-by":"crossref","unstructured":"CD93 Blockade Stabilizes Tumor Vasculature to Improve Therapy Response, Cancer Discov 11(10) (2021) 23682021.","DOI":"10.1158\/2159-8290.CD-RW2021-113"},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12935-023-03044-z","article-title":"Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.phrs.2026.108118_bib23","article-title":"Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response","volume":"8","author":"Tong","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.phrs.2026.108118_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijbiomac.2022.10.136","article-title":"Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells","volume":"224","author":"Barbera","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108118_bib25","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1172\/JCI97459","article-title":"CD93 promotes \u03b21 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis","volume":"128","author":"Lugano","year":"2018","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2026.108118_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.898493","article-title":"IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer","volume":"13","author":"Yi","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2026.108118_bib27","article-title":"CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41420-023-01336-x","article-title":"Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2\/FGFR1\/PI3K\/AKT axis","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov."},{"issue":"10","key":"10.1016\/j.phrs.2026.108118_bib29","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1016\/j.ymthe.2025.07.042","article-title":"CD93 blockade overcomes sunitinib resistance in pancreatic neuroendocrine tumors","volume":"33","author":"Sun","year":"2025","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2026.108118_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010148","article-title":"Targeting CD93 on monocytes revitalizes antitumor immunity by enhancing the function and infiltration of CD8(+) T cells","volume":"12","author":"Jiang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.108118_bib31","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7150\/thno.89144","article-title":"Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2026.108118_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216268","article-title":"Particle radiotherapy in the era of radioimmunotherapy","volume":"567","author":"Zhou","year":"2023","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.phrs.2026.108118_bib33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/HEP.0000000000000776","article-title":"Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study","volume":"80","author":"Zhu","year":"2024","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2026.108118_bib34","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/2326-6066.CIR-17-0640","article-title":"Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1\/PD-L1 Blockade in Lung Cancer","volume":"7","author":"Zhao","year":"2019","journal-title":"Cancer Immunol. Res"},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib36","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41467-022-30861-z","article-title":"Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8(+) T cells","volume":"13","author":"Mizukoshi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108118_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jconrel.2021.04.036","article-title":"An orally available PD-1\/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy","volume":"334","author":"Li","year":"2021","journal-title":"J. Control Release"},{"issue":"6","key":"10.1016\/j.phrs.2026.108118_bib38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.apsb.2020.01.005","article-title":"A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8(+) T cell responses","volume":"10","author":"Zhai","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"35","key":"10.1016\/j.phrs.2026.108118_bib39","doi-asserted-by":"crossref","first-page":"15114","DOI":"10.1002\/anie.202002783","article-title":"A Novel d-Peptide identified by mirror-image phage display blocks TIGIT\/PVR for cancer immunotherapy","volume":"59","author":"Zhou","year":"2020","journal-title":"Angew. Chem. Int Ed. Engl."},{"issue":"2","key":"10.1016\/j.phrs.2026.108118_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000905","article-title":"CD47\/SIRP\u03b1 blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy","volume":"8","author":"Wang","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.phrs.2026.108118_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007068","article-title":"Discovery of a novel dual-targeting D-peptide to block CD24\/Siglec-10 and PD-1\/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy","volume":"11","author":"Shen","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.108118_bib42","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/D0CS00556H","article-title":"Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs)","volume":"50","author":"Cooper","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phrs.2026.108118_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2019.00155","article-title":"The discovery and development of liraglutide and semaglutide","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.phrs.2026.108118_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106343","article-title":"A PD-L1 and VEGFR2 dual targeted peptide and its combination with irradiation for cancer immunotherapy","volume":"182","author":"Jiao","year":"2022","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13046-019-1156-5","article-title":"ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108118_bib46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccell.2023.02.002","article-title":"High endothelial venules in cancer: regulation, function, and therapeutic implication","volume":"41","author":"Vella","year":"2023","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.phrs.2026.108118_bib47","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s12276-021-00640-9","article-title":"Tumor microenvironment and radioresistance","volume":"53","author":"Suwa","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"8024","key":"10.1016\/j.phrs.2026.108118_bib48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07698-1","article-title":"Tumour vasculature at single-cell resolution","volume":"632","author":"Pan","year":"2024","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.phrs.2026.108118_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300286","article-title":"In situ vaccination with mitochondria-targeting immunogenic death inducer elicits CD8(+) T cell-dependent antitumor immunity to boost tumor immunotherapy","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2026.108118_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.matbio.2019.08.002","article-title":"Multimerin-2 maintains vascular stability and permeability","volume":"87","author":"Pellicani","year":"2020","journal-title":"Matrix Biol."},{"issue":"26","key":"10.1016\/j.phrs.2026.108118_bib51","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/onc.2011.487","article-title":"MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A\/VEGFR2 pathway","volume":"31","author":"Lorenzon","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.phrs.2026.108118_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010554","article-title":"CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors","volume":"13","author":"Sun","year":"2025","journal-title":"J. Immunother. Cancer"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:29:07Z","timestamp":1777606147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826000332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"alternative-id":["S1043661826000332"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108118","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel peptide blocking CD93\/IGFBP7 interaction normalizes tumor vessels and synergizes with radiotherapy for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108118"}}